Algernon Pharmaceuticals Stock Today
| AGNPF Stock | USD 0.05 0 2.99% |
Performance0 of 100
| Odds Of DistressOver 68
|
Algernon Pharmaceuticals is trading at 0.052 as of the 11th of December 2024. This is a 2.99 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0517. Algernon Pharmaceuticals has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. Algernon Pharmaceuticals is traded on OTC Exchange in the United States. The company has 2.41 M outstanding shares. More on Algernon Pharmaceuticals
Moving together with Algernon OTC Stock
| 0.68 | NVO | Novo Nordisk AS | PairCorr |
| 0.63 | NONOF | Novo Nordisk AS | PairCorr |
| 0.62 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Algernon OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Algernon OTC Stock Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Algernon Pharmaceuticals [AGNPF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Algernon Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Algernon Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Algernon Pharmaceuticals classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 2.41 M outstanding shares.
Algernon Pharmaceuticals has accumulated about 872.84 K in cash with (2.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Algernon Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAlmost 83.57 percent of Algernon Pharmaceuticals outstanding shares are held by general public with 1.7 (percent) owned by insiders and only 14.73 % by other corporate entities.
Check Algernon Ownership Details
Algernon Pharmaceuticals Risk Profiles
| Mean Deviation | 6.86 | |||
| Standard Deviation | 10.46 | |||
| Variance | 109.36 | |||
| Risk Adjusted Performance | 0.0053 |
Algernon Stock Against Markets
Picking the right benchmark for Algernon Pharmaceuticals otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Algernon Pharmaceuticals otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Algernon Pharmaceuticals is critical whether you are bullish or bearish towards Algernon Pharmaceuticals at a given time. Please also check how Algernon Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Algernon Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Other Information on Investing in Algernon OTC Stock
Algernon Pharmaceuticals financial ratios help investors to determine whether Algernon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Algernon with respect to the benefits of owning Algernon Pharmaceuticals security.